QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Her, S. Articles by Wong, D. L. Search for Related Content PubMed PubMed Citation Articles by Her, S. Articles by Wong, D. L.

Regulation of the Rat Phenylethanolamine N-Methyltransferase Gene by Transcription Factors Sp1 and MAZ

Department of Psychiatry, Harvard Medical School Laboratory of Molecular and Developmental Neurobiology, McLean Hospital, Belmont, Massachusetts

The rat phenylethanolamine N-methyltransferase (PNMT) gene promoter contains 1-base pair (bp) overlapping consensus sequences for Sp1 and MAZ transcription factors at -48 and -38 bp, respectively. Gel mobility assays using PC-12-derived RS1 cell nuclear extracts or in vitro translated proteins showed that Sp1 and MAZ specifically bind to these elements, that MAZ displaces/prevents Sp1 binding, and that Sp1 and MAZ binding is mutually exclusive, with occupancy dependent on each factor's concentration and affinity for its consensus element. In transfection assays, PNMT promoter activation by Sp1 and MAZ depends on promoter length, with -893 bp of sequence yielding greatest activation. Although MAZ has higher affinity for its binding element, it is a less effective activator. Changes in PNMT promoter activity for the constructs pGL3RP60 or pGL3RP893 using a fixed amount of MAZ expression construct and a variable amount of Sp1 expression construct or vice versa confirmed the latter. Mutation of the MAZ or Sp1 sites in pGL3RP60 attenuated but did not eliminate PNMT promoter activity, even though the proteins no longer bind to their consensus elements. Phosphatase treatment of RS1 cell nuclear extracts prevented MAZ- and Sp1-DNA binding complex formation. Although MAZ and Sp1 elevate endogenous PNMT mRNA in RS1 cells, MAZ preferentially increases intron-retaining whereas Sp1 preferentially increases intronless mRNA. Thus, expression of the PNMT gene seems to be modulated through competitive binding of phosphorylated Sp1 and MAZ to their consensus elements in the promoter. In addition, post-transcriptional regulation seems to be another important mechanism controlling PNMT expression.

Address correspondence to: Dr. Dona Lee Wong, Department of Psychiatry, Harvard Medical School Laboratory of Molecular and Developmental Neurobiology, McLean Hospital, 115 Mill Street, Rm 116, Belmont, MA 02478. E-mail: dona_wong{at}hms.harvard.edu

This article has been cited by other articles:

				C. L. Himeda, J. A. Ranish, and S. D. Hauschka Quantitative Proteomic Identification of MAZ as a Transcriptional Regulator of Muscle-Specific Genes in Skeletal and Cardiac Myocytes Mol. Cell. Biol., October 15, 2008; 28(20): 6521 - 6535. [Abstract] [Full Text] [PDF]

				T. C. Tai, D. C. Wong-Faull, R. Claycomb, and D. L. Wong Nerve Growth Factor Regulates Adrenergic Expression Mol. Pharmacol., November 1, 2006; 70(5): 1792 - 1801. [Abstract] [Full Text] [PDF]

				P.-W. Lee, S. Wu, and Y.-M. Lee Differential Expression of {micro}-Opioid Receptor Gene in CXBK and B6 Mice by Sp1 Mol. Pharmacol., December 1, 2004; 66(6): 1580 - 1584. [Abstract] [Full Text] [PDF]